Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov release/version identifier (“Revision: v3.5.3”) instead of the previous one (“v3.5.2”), with no other study-details text change shown.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page header.SummaryDifference0.1%

- Check52 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1. This update is a UI/version label change and does not alter study content or functionality.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.4.1 has been added, replacing the previous v3.4.0. This appears to be a minor, non-user-facing update with no visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.